Results 11 to 20 of about 8,311 (216)
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE [PDF]
Mediterranean Journal of Hematology and Infectious Diseases, 2018 Waldenstrom Macroglobulinemia is a rare lymphoproliferative disorder with distinctive clinical features. Diagnostic and prognostic charactrization in WM significantly changed with the discovery of two molecular markers: MYD88 and CXCR4. Mutational status
Maddalena Mazzucchelli +4 more
doaj +5 more sources
A 44-Year-Old Man with Waldenstrom Macroglobulinemia and Bilateral Maxillary Sinusitis [PDF]
Acta Medica Indonesiana, 2017 Waldenstrom macroglobulinemia is a chronic, indolent, lymphoproliferative disorder, which is characterized by the presence of a high macroglobulin (IgM) level, elevated serum viscosity, and the presence of a lymphoplasmacytic infiltrate in the bone ...
Shinta Oktya Wardhani +2 more
doaj +5 more sources
Unusual presentation of Waldenstrom macroglobulinemia
Journal of Cancer Research and Practice, 2018 A 62-year-old Taiwanese man presented to our hospital with soft masses over his right shoulder and left elbow that had rapidly developed over the previous three months.
Chih-Yu Chang +8 more
doaj +2 more sources
Waldenström Macroglobulinemia: Unusual Presentation With Cast Nephropathy/Light Chain Tubulopathy
Clinical Medicine Insights: Case Reports, 2019 Cast Nephropathy/Light chain tubulopathy is usually present in patients with multiple myeloma and is very rare in patients with Waldenstrom Macroglobulinemia. There are very few case reports mentioned in the literature.
Muddasir Ashraf, Prerna Rastogi
doaj +2 more sources
Waldenstrom Macroglobulinemia Complicated with Hyperviscosity Syndrome [PDF]
Central Asian Journal of Medical Sciences, 2015 Objectives: Waldenstrom Macroglobulinemia (WM) is a malignant disease of the B lymphocytes. We report on a patient in Mongolia having WM complicated with hyperviscosity syndrome.
Narangerel Jigjidkhorol +9 more
doaj +2 more sources
Waldenstrom Macroglobulinemia [PDF]
Cancer Letters, 2008 In the past years, new developments have occurred both in the understanding of the biology of Waldenstrom Macroglobulinemia (WM) and in therapeutic options for WM. WM is a B-cell disorder characterized primarily by bone marrow infiltration with lymphoplasmacytic cells, along with demonstration of an IgM monoclonal gammopathy.
Xavier, Leleu +8 more
openaire +3 more sources
A Rare Case of Waldenstrom Macroglobulinemia Presenting as Pancytopenia
, 2023 <p>Monoclonal gammopathy of any concentration. It's a variant of Lymphoplasmacytic lymphoma with Bone marrow involvement & IgM monoclonal gammopathy. Waldenstrom macroglobulinemia constitute around 2% of hematological malignancy.
Dr Anil Agrawal, Ms Nimisha Shende
core +1 more source
How to manage Waldenstrom’s macroglobulinemia [PDF]
Leukemia, 2013 Waldenstrom's macroglobulinemia (WM) is very distinct from other indolent lymphoma subtypes: by definition it is accompanied by a monoclonal IgM gammopathy; it presents always with bone marrow infiltration and often with clinical symptoms such as neuropathy or hyperviscosity.
Buske, C, Leblond, V
openaire +2 more sources
Treatment of Waldenstrom’s Macroglobulinemia
Current Treatment Options in Oncology, 2007 Waldenstrom's macroglobulinemia is defined by bone marrow lymphoplasmacytic infiltration and by production of monoclonal IgM. Treatment is employed only to symptomatic patients. Alkylating agents (chlorambucil), nucleoside analogues and rituximab are reasonable choices for primary therapy.
Dimopoulos, Meletios A +1 more
openaire +4 more sources
Waldenstrom Macroglobulinemia Presenting with Pancreatic Mass: A Case Report and Review of Literature [PDF]
, 2013 Context Waldenstrom macroglobulinemia is a rare lymphoplasmacytic lymphoma characterized by a wide range of clinical presentations related to direct tumor infiltration and the production of IgM.
Kumar, Naresh +7 more
core +1 more source